Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Galit Alter

Showing results (491-500 of 535) with videos related to

Pageof 54
Sort By:
Cell Host & Microbe|January 11, 2019
A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman PrimatesZachary A Bornholdt, Andrew S Herbert, Chad E Mire, et al.
Plos Pathogens|December 8, 2020
RV144 HIV-1 vaccination impacts post-infection antibody responsesThembi Mdluli, Ningbo Jian, Bonnie Slike, et al.
Annals of the New York Academy of Sciences|January 14, 2022
Innovative vaccine approaches-a Keystone Symposia reportJennifer Cable, Rino Rappuoli, Elizabeth J Klemm, et al.
Biorxiv : the Preprint Server for Biology|October 13, 2021
Longitudinal characterization of circulating neutrophils uncovers distinct phenotypes associated with disease severity in hospitalized COVID-19 patientsThomas J LaSalle, Anna L K Gonye, Samuel S Freeman, et al.
Plos Neglected Tropical Diseases|July 5, 2023
Schistosoma mansoni infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responsesRoshell Muir, Talibah Metcalf, Slim Fourati, et al.
Immunity|July 22, 2018
Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus GlycoproteinPavlo Gilchuk, Natalia Kuzmina, Philipp A Ilinykh, et al.
The New England Journal of Medicine|November 11, 2020
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised HostBina Choi, Manish C Choudhary, James Regan, et al.
Plos Pathogens|March 2, 2021
Correction: RV144 HIV-1 vaccination impacts post-infection antibody responsesThembi Mdluli, Ningbo Jian, Bonnie Slike, et al.
Nature Biomedical Engineering|August 5, 2020
Integrated pipeline for the accelerated discovery of antiviral antibody therapeuticsPavlo Gilchuk, Robin G Bombardi, Jesse H Erasmus, et al.
Science (New York, N.Y.)|July 4, 2015
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeysDan H Barouch, Galit Alter, Thomas Broge, et al.
Pageof 54

Showing results (491-500 of 535) with videos related to

Sort By:
Pageof 54
Cell Host & Microbe|January 11, 2019
A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman PrimatesZachary A Bornholdt, Andrew S Herbert, Chad E Mire, et al.
Plos Pathogens|December 8, 2020
RV144 HIV-1 vaccination impacts post-infection antibody responsesThembi Mdluli, Ningbo Jian, Bonnie Slike, et al.
Annals of the New York Academy of Sciences|January 14, 2022
Innovative vaccine approaches-a Keystone Symposia reportJennifer Cable, Rino Rappuoli, Elizabeth J Klemm, et al.
Biorxiv : the Preprint Server for Biology|October 13, 2021
Longitudinal characterization of circulating neutrophils uncovers distinct phenotypes associated with disease severity in hospitalized COVID-19 patientsThomas J LaSalle, Anna L K Gonye, Samuel S Freeman, et al.
Plos Neglected Tropical Diseases|July 5, 2023
Schistosoma mansoni infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responsesRoshell Muir, Talibah Metcalf, Slim Fourati, et al.
Immunity|July 22, 2018
Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus GlycoproteinPavlo Gilchuk, Natalia Kuzmina, Philipp A Ilinykh, et al.
The New England Journal of Medicine|November 11, 2020
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised HostBina Choi, Manish C Choudhary, James Regan, et al.
Plos Pathogens|March 2, 2021
Correction: RV144 HIV-1 vaccination impacts post-infection antibody responsesThembi Mdluli, Ningbo Jian, Bonnie Slike, et al.
Nature Biomedical Engineering|August 5, 2020
Integrated pipeline for the accelerated discovery of antiviral antibody therapeuticsPavlo Gilchuk, Robin G Bombardi, Jesse H Erasmus, et al.
Science (New York, N.Y.)|July 4, 2015
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeysDan H Barouch, Galit Alter, Thomas Broge, et al.
Pageof 54